MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Ernexa Therapeutics Inc. (ERNAW)

Ernexa Therapeutics Inc. (ERNAW)

||
||

Balance Sheets Overview

Current Ratio
201.02%
Quick Ratio
201.02%
Debt to Asset Ratio
49.33%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash
    • Prepaid expenses and other curre...
    • Right-of-use assets - operating ...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
Cash
5,028
9,177
1,884
Other receivables
-
-
95
Due from related party
83
95
750
Prepaid expenses and other current assets
783
724
404
Total current assets
5,894
9,996
3,133
Property and equipment, gross
-
-
291
Less accumulated depreciation and amortization
-
-
197
Property and equipment, net
82
88
94
Right-of-use assets - operating leases, net
314
349
453
Goodwill
-
-
2,044
Other assets
25
110
110
Total assets
6,315
10,543
5,834
Accounts payable
1,375
1,300
1,125
Accrued expenses
1,016
1,481
898
Income taxes payable
-
4
3
Operating lease liabilities, current
167
163
213
Due to related party
250
250
750
Contingent consideration liability
-
41
41
Other current liabilities
124
218
83
Total current liabilities
2,932
3,457
3,113
Operating lease liabilities, non-current
182
226
277
Other liabilities
1
1
43
Total liabilities
3,115
3,684
3,433
Preferred stock, 0.005 par value, 1,000 shares authorized, 156 designated and outstanding of series a convertible preferred stock at june 30, 2026 and december 31, 2025, 156 liquidation preference
1
1
1
Common stock, 0.005 par value, 150,000 shares authorized at june 30, 2026 and december 31, 2025, 1,170 and 314 issued and outstanding at june 30, 2026 and december 31, 2025, respectively
6
6
39
Additional paid-in capital
258,352
257,994
247,997
Accumulated deficit
-255,159
-251,142
-245,636
Total stockholders equity
3,200
6,859
2,401
Total liabilities and stockholders equity
6,315
10,543
5,834
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$5,028K Prepaid expenses andother current assets$783K Due from relatedparty$83K Total current assets$5,894K Right-of-use assets -operating leases, net$314K Property and equipment,net$82K Other assets$25K Total assets$6,315K Total liabilities andstockholders equity$6,315K Total stockholdersequity$3,200K Total liabilities$3,115K Accumulated deficit-$255,159K Additional paid-in capital$258,352K Total currentliabilities$2,932K Operating leaseliabilities, non-current$182K Other liabilities$1K Common stock, 0.005 parvalue, 150,000 shares...$6K Preferred stock, 0.005 parvalue, 1,000 shares...$1K Accounts payable$1,375K Accrued expenses$1,016K Due to related party$250K Operating leaseliabilities, current$167K Other currentliabilities$124K